Second-generation anaplastic lymphoma kinase inhibitors: revolutionary or evolutionary?

Lignende værker

• New generation anaplastic lymphoma kinase inhibitors
  af: Delmonte, Angelo, et al.
  Udgivet: (2019)
• Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
  af: van Erp, Anke E. M., et al.
  Udgivet: (2017)
• Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance
  af: Song, Zilan, et al.
  Udgivet: (2015)
• Current evidence in support of the second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor alectinib for the treatment of non-small cell lung cancer positive for ALK translocation
  af: Hayashi, Hidetoshi, et al.
  Udgivet: (2016)
• Anaplastic lymphoma kinase inhibitor-associated myositis
  af: Uruha, Akinori, et al.
  Udgivet: (2020)